Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Kane Biotech Inc. V.KNE

Alternate Symbol(s):  KNBIF

Healthcare Biotechnology
Kane Biotech Inc. is a Canada-based biotechnology company. The Company is engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. It has a portfolio of biotechnologies and products, which includes StrixNB, DispersinB, Aledex, bluestem, bluestem, silkstem, goldstem, coactiv+, coactiv+, DermaKB and DermaKB Biofilm. Its... see more

Recent & Breaking News (TSXV:KNE)

Kane Biotech Sues Nestlé

GlobeNewswire February 26, 2018

Kane Biotech Provides Additional Information Regarding Engagement of Investor Relations Counsel

GlobeNewswire February 1, 2018

Kane Biotech Retains Edison Advisors as Investor Relations Counsel

GlobeNewswire February 1, 2018

Kane Biotech Announces Trading on the OTCQB Venture Market

GlobeNewswire January 31, 2018

Kane Biotech – Q3 2017 Financial Results, Resignation of Director and Granting of Options

GlobeNewswire November 14, 2017

Kane Biotech Inc. Provides Overview of Biofilm Industry, Clinical Development and Growth Drivers in New SNNLive Video Interview with StockNewsNow.com

Accesswire October 30, 2017

Kane Biotech Inc. to Present at The MicroCap Conference on October 5th in New York City at the Essex House

Accesswire September 18, 2017

Kane Biotech Announces New Chief Financial Officer

GlobeNewswire September 5, 2017

Kane Biotech Announces Second Closing of Private Placement Offering and Resignation of Director

GlobeNewswire August 18, 2017

Kane Biotech – Q2 2017 Financial Results

GlobeNewswire August 16, 2017

Kane Biotech Announces Removal of All Debt from its Balance Sheet and Grant of Options

MarketWire Canada July 24, 2017

Kane Biotech Announces Closing of Over-Sold Private Placement Offering

Marketwired July 17, 2017

Kane Biotech Announces Closing of Loan Transaction

Marketwired June 27, 2017

Kane Biotech Inc. to Present at The MicroCap Conference on June 27th in Toronto at the Sheraton Centre Hotel

Accesswire June 12, 2017

Kane Biotech Announces Private Placement Offering

MarketWire Canada June 1, 2017

Kane Biotech - Q1 2017 Financial Reports

MarketWire Canada May 17, 2017

Kane Biotech - Business and Intellectual Property Update

MarketWire Canada May 11, 2017

Kane Biotech Announces Issuance of Common Shares in Payment of Outstanding Interest

Marketwired March 27, 2017

Kane Biotech Announces Completion of Share Consolidation

MarketWire Canada March 10, 2017

Kane Biotech Announces Exclusive License and Distribution Agreement with Dechra

Marketwired March 6, 2017